Clinical Trials

48 enrolled

Non-squamous Non-small-cell Lung Cancer

NCT05208177 2025-08-22

A Study of SHR-1802 in Patients With Advanced Solid Tumor

Phase 2 Terminated

25 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04680988 2025-08-05

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

194 enrolled

Gynecologic

Uterine Cervical Neoplasms, Recurrence

NCT04409223 2024-02-09

Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib

185 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04346381 2023-09-18

Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor

233 enrolled

Other solid neoplasm

Solid Tumor

NCT05106335 2023-08-16

A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLC

1 enrolled

Advanced NSCLC

NCT05042375 2022-11-17

A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Phase 3 Unknown

450 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03827837 2022-07-01

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

Phase 2 Unknown

265 enrolled

GenitourinaryGynecologic

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT04679038 2022-01-26

A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

222 enrolled

Other solid neoplasm

Solid Tumor

NCT05020925 2021-08-25

SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 1/2 Unknown

30 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04479904 2021-06-22

A Trial of Famitinib in Patients With Failure of First-Line Treatment For Intrahepatic Cholangiocarcinoma

Phase 2 Withdrawn

Gastrointestinal

Cholangiocarcinoma

NCT02390947 2020-12-22

FACT

Phase 3 Completed

543 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02356991 2019-11-04

A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Suspended

137 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01392235 2019-01-22

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

EndocrineGastrointestinalNET

58 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01994213 2019-01-22

A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor

Phase 2 Terminated

53 enrolled

Gastro-enteropancreatic neuroendocrine tumor

NCT02766140 2019-01-18

SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer

12 enrolled

Non Squamous Non Small Cell Lung

NCT01829841 2018-05-03

A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer

150 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT01762293 2018-04-18

A Study of Famitinib in Patients With Advanced Colorectal Cancer